- Research article
- Open Access
Accuracy and efficiency define Bxb1 integrase as the best of fifteen candidate serine recombinases for the integration of DNA into the human genome
BMC Biotechnology volume 13, Article number: 87 (2013)
Phage-encoded serine integrases, such as φC31 integrase, are widely used for genome engineering. Fifteen such integrases have been described but their utility for genome engineering has not been compared in uniform assays.
We have compared fifteen serine integrases for their utility for DNA manipulations in mammalian cells after first demonstrating that all were functional in E. coli. Chromosomal recombination reporters were used to show that seven integrases were active on chromosomally integrated DNA in human fibroblasts and mouse embryonic stem cells. Five of the remaining eight enzymes were active on extra-chromosomal substrates thereby demonstrating that the ability to mediate extra-chromosomal recombination is no guide to ability to mediate site-specific recombination on integrated DNA. All the integrases that were active on integrated DNA also promoted DNA integration reactions that were not mediated through conservative site-specific recombination or damaged the recombination sites but the extent of these aberrant reactions varied over at least an order of magnitude. Bxb1 integrase yielded approximately two-fold more recombinants and displayed about two fold less damage to the recombination sites than the next best recombinase; φC31 integrase.
We conclude that the Bxb1 and φC31 integrases are the reagents of choice for genome engineering in vertebrate cells and that DNA damage repair is a major limitation upon the utility of this class of site-specific recombinase.
Serine integrases are phage-encoded site-specific recombinases that promote conservative recombination reactions between short (40-60 bp) DNA substrates located on the phage (phage attachment site, attP) and bacterial (bacterial attachment site, attB) chromosomes . The product of attP × attB recombination is an integrated prophage flanked by two new recombination sites, attL and attR, each containing half sites derived from attP and attB. In the absence of accessory factors the integrases mediate unidirectional recombination between attP and attB with greater than 80% efficiency. In the presence of a phage-encoded accessory protein, the recombination directionality factor (RDF) the attP × attB recombination is inhibited and the attL × attR recombination is stimulated [2, 3]. In this way integration (attP × attB) and excision (attL × attR) of the phage genome are under strict controls and in tune with the phage life cycles. The unidirectional activity, short substrate sites and functional autonomy of these recombinases has made them a useful complement to the widely used reversible recombinases of the tyrosine recombinase family such as Cre and Flp for genome engineering reviewed in . In particular the unidirectional activity has made them valuable for the promotion of DNA integration by recombinase-mediated cassette exchange reactions and for the development of iterative recombination approaches [4–7]. To date five serine integrases derived from phages φC31 , φBT1 , Bxb1 [10, 11] and R4 [11, 12] have been shown to be capable of promoting site-specific integration of DNA into mammalian genomes while TP901-1 , A118, FC1 and φRV  have been shown to promote site-specific recombination in an extra-chromosomal environment in mammalian cells. With one exception these studies have, however, been carried out largely independently of one another, in different cell lines, cells of different species and using different protocols. The exceptional study was that of Yamaguchi and colleagues  who compared the activities of the φC31, Bxb1, TP901-1 and R4 integrases in mediating site-specific recombination into a human artificial chromosome (HAC) isolated in hamster cells. This study exploited a promoter trap strategy and thus relied upon selection to assay recombination products. Importantly, however, the products were not analyzed at the level of DNA sequence. It was therefore neither possible to determine the total level of recombination promoted by these different enzymes nor to determine the fraction of recombination events that had proceeded by reciprocal and conservative site-specific recombination.
The discovery that site-specific recombination mediated by the φC31 integrase is sometimes accompanied by DNA damage in vertebrate cells identified  posed the question as how far integrase associated DNA damage limits the use of the serine integrases as genome engineering reagents. Damage of the type seen with the φC31 integrase, has not been detected with the tyrosine recombinases, is likely to be a consequence of the DNA cleavage and strand exchange mechanism of the serine recombinases (reviewed in ). The recombination pathway begins with binding of integrase to the attachment sites, which are then brought together by protein:protein interactions to form a synaptic tetramer. The reaction then proceeds by the formation of concerted double strand breaks in both of the DNA substrates prior to subunit rotation and recombination. It seems likely that the damage that accompanies the activity of these recombinases in vertebrate cells arises as a consequence of these double strand breaks being recognized by the mammalian cell double strand break repair pathways. It should be noted that to date no damage has ever been observed to accompany the action of the serine integrases in bacteria and it may therefore be the eukaryotic chromatin environment or the nature of the mammalian repair pathways that leads to the damage seen in mammalian cells. The frequency and extent of the damage would seem likely to reflect the time spent by the integrases in the covalently linked, cleaved DNA complex as this is most likely to be the target for the repair pathways.
In total there are fifteen phage-encoded serine integrases for which both of their attachment sites are known. Nine of these fifteen integrases have been characterised in reactions in mammalian cells, E. coli or in vitro (φC31 , Bxb1 , φBT1 , φC1 [14, 20], MR11 , TP901-1 , R4 , A118 , and φRV , ) while six (TG1, φ370.1 , Wβ , BL3, SPBc and K38) have not yet been shown to be active outside their native hosts. In total there are ten integrases whose utility as tools for integrating DNA into mammalian genomes has not been investigated. We have therefore set out to rank the activities of all fifteen of these serine integrases for which the sites are known by the criteria of both accuracy and efficiency in two different mammalian cell lines; human HT1080 cells and mouse ES cells. These studies have provided us with a clear rank order for the utility of this important class of enzymes as tools for vertebrate genome engineering with Bxb1 integrase mediating the most efficient and accurate site-specific recombination in this heterologous environment. The φC31 integrase comes a close second. For the remaining integrases, we demonstrate that DNA damage is an important factor in limiting the utility of members of this class of enzymes for promoting integration reactions in mammalian cells.
Results and discussion
Fifteen unidirectional 'phage integrases are active in E. coli
Fifteen unidirectional phage integrases have been described for which the attachment sites are known. We first set out to confirm that each integrase and their cognate attachment sites were active by expression of each integrase gene in E. coli in the presence of a reporter plasmid. Fifteen reporter plasmids (conferring chloramphenicol resistance) were constructed in which the lacZα gene was flanked by attB and attP sites for each of the respective integrases (Figure 1A). These plasmids conferred exclusively blue colony when transformed into an E. coli strain containing the lacZΔM15 mutation and plated on selective agar in the presence of X-gal and IPTG (Figure 1B, top row). We next introduced genes encoding each one of the integrases tagged at the N-terminal end by a StrepII tag and at the C-terminal end by a SV40 large T antigen nuclear localization signal into the E. coli expression plasmid pET21a (conferring ampicillin resistance). Initially we introduced the integrase expression plasmids into DH5α E. coli K12 strains containing a cognate reporter plasmid and scored the transformants as white or light blue, indicative of recombination, or blue, indicative of no recombination. Active integrases were from phages φC31, Bxb1, TG1, TP901-1, A118, SPBc, Wβ, φBT1 and φ370.1 in this assay (Figure 1B, middle row). The transformants containing integrase genes that only gave rise to blue or light blue colonies were picked and restreaked to single colonies and white colonies were observed from strains expressing BL3, FC1 and K38 integrases whereas no white segregants were observed from strains containing MR11, φRV and R4 int genes (Figure 1B, bottom row).
As the expression of the integrases might be limiting in bacteria containing the MR11, φRV and R4 integrase genes, we repeated the recombination assay in E. coli BL21(DE3), a strain that should over-express the integrase genes on induction with IPTG. Competent BL21(DE3) containing the different reporter plasmids were prepared and the integrase containing expression plasmids introduced by transformation with selection for ampicillin and chloramphenicol resistance. Expression of integrase was induced by addition of IPTG to logarithmically growing cells and cultures were further incubated overnight at 20°C. Plasmid DNA was extracted from 1 ml of each culture and used to transform plasmid free DH5α scoring for white and blue colonies. All of the plasmids extracted from the E. coli BL21(DE3) cells expressing the integrases gave exclusively white colonies with the exception of strains that had contained MR11 or φRV integrases, which yielded 50% and 25% unrecombined plasmid, respectively (Table 1). The control BL21(DE3) strains that contained the reporter plasmids and the empty expression plasmid (pET21a) remained stable with no loss of the lacZα gene. Accurate site-specific recombination for all of the integrases was confirmed by PCR and sequencing of the attL sites recovered from plasmids present in the white colonies. Cells from the same cultures were used to assay the level of expression of the StrepII-tagged integrases by western blots (Table 1). A StrepII-tagged integrase of the expected molecular weight was detected from all the BL21 (DE3) strains expressing an integrase except those containing the Wβ, Bxb1, BL3 or R4 integrase genes. The amount of protein present was determined by comparing the intensities of the bands from the western blotting with those from a series of standards (Table 1). While there was no simple relationship between the amounts of protein detected in the cultures and the level of recombination, this experiment demonstrated that all the integrases and their attachment sites were active in E. coli.
Assaying the unidirectional phage integrases in vertebrate cells
The activities of the integrases were then measured in vertebrate cells. In order to do this we constructed three reporter plasmids that could be used to assay the ability of all of the different integrases to mediate either deletion or integration in mammalian cells. Each of the reporter plasmids included arrays containing attP or attB sites for all 15 integrases arranged head-to-tail. For the deletion assay we used a plasmid, called 'attP array CCAG HyTK attB array’ (Figure 2A), in which a counter selectable marker gene, a fusion between a gene conferring resistance to hygromycin and a herpes simplex virus thymidine kinase gene that confers sensitivity to the nucleoside analogue gancyclovir, HyTK, was placed between arrays of attB and attP sites in a head-to-tail orientation (Figures 2B and 2C). If integrase mediated recombination occurs between its cognate attP and attB sites flanking the HyTK gene, the cells become resistant to gancyclovir. The assay for integration activity was based upon the use of two plasmids. The first of these, called 'attP array CCAG HyTK attP array’, contained the docking attP sites, flanking the counter selectable marker (Figure 2A) and the second, called 'attB array CCAG neo attB array’, contained the incoming attB sites flanking a gene encoding resistance to the antibiotic G418 (Figure 2D). Cassette exchange between the incoming attB sites and the docking attP sites is expected to yield chromosomes containing attR and attL flanking the integrated neo gene and the cells display both gangcylovir and G418 resistance.
In both assays the integrases were expressed using plasmids (Figure 2E) in which each integrase gene had been codon optimized and tags placed at the 5′ and 3′ ends encoding the StrepII tag and the nuclear localization signal. An internal ribosome entry site (IRES) followed by an antibiotic resistance gene was placed downstream of each integrase gene.
The use of arrays of attachment sites in the reporter plasmids had three merits: Firstly it enabled a strategy that ensured that comparisons between the different integrases were not compromised by position effects arising as a result of the target sites for the different integrases being integrated at different positions in the vertebrate genome. Secondly it allowed us to determine whether there was any cross-reactivity between the different integrases and their attachment sites. Finally this approach proved to be efficient, requiring only a small number of cell lines to be used for all of the necessary assays. However as a precaution, we wanted to exclude the possibility that placing the attachment sites within an array altered their activity and so we compared the in vitro activity of one of the integrases, φC31 integrase, using substrates in which the attachment sites were either isolated or present in the arrays (Figure 3A-E). These experiments showed that the recombination efficiencies of the attachment sites were similar whether they were isolated or present in the arrays.
Identification of eight unidirectional phage integrases promoting site-specific deletion in mammalian cells
Firstly we wanted to determine which of the fifteen integrases were active on substrates integrated into vertebrate genomes. The most sensitive way in which to detect activity is to assay recombination between attB and an attP sites in cis because the proximity of the sites favours the kinetics of synapsis, the process by which integrase bring the substrates together in a tetramer prior to DNA cleavage. We therefore transfected the construct designed to assay deletion, attP array CCAG HyTK attB array, into human HT1080 cells by electroporation and selected for stable transfectants using hygromycin. We screened 96 stably transfected clones for the integrity of the integrated DNA using PCR, checked for single copy integrants by restriction enzyme analysis and filter hybridization and then confirmed the integrity of the attP and attB arrays by sequencing. In this way we recovered four independent, stably transfected clones from two independent transfections, each containing a single copy of the integrated deletion reporter construct, attP array CCAG HyTK attB array.
In order to compare the activities of the different integrases we first transiently transfected 105 HT1080 cells containing the attP array CCAG HyTK attB array reporter with expression plasmids for each of the integrases using Lipofectamine and assayed for recombination activity by selecting for resistance to gancyclovir, a drug which is selectively toxic for cells expressing the HyTK fusion. None of the integrases gave a significant increase in the number of gancyclovir-resistant cells as compared to the empty expression vector (Adiitional file 1: Table S3) and so we assayed pools of the resistant cells for the presence of the recombinant attR site using PCR. Recombination activity was detected in populations of cells transfected with the R4, φC31, φBT1, Bxb1, SPBC and Wβ integrase expression constructs (not shown). However the low level of activity overall made it impossible to conclude anything about the integrases that did not yield attR in the PCR reactions as the integrases may be active but causing damage that removed the attR primer binding sites, may simply be slow in promoting site-specific recombination or completely inactive. Moreover the variability of the relative numbers of gancyclovir resistant clones generated in different experiments made an accurate comparison between the active integrases impractical.
We therefore used electroporation to transfect linearized integrase expression constructs into each of the two independent cell lines containing the attP array CCAG HyTK attB array reporter used in the transient expression experiments and selected for clones containing stably integrated, integrase expression constructs (Additional file 1: Table S4). The yield of clones generated by the integrase expression constructs was at least an order of magnitude lower than those recovered following transfection with the empty expression vector suggesting that all of the integrases were toxic to various degrees. The TG1 and φ370.1 integrases appeared particularly toxic by this criterion because these consistently gave us no stably transfected clones. We divided the clones that had been stably transfected with each of the integrases into two groups of approximately equal sizes. We used the first of these groups to estimate the ability of the integrases to promote site-specific recombination of the attP array CCAG HyTK attB array reporter construct within the first two weeks of exposure to integrase. In order to do this we applied gancyclovir selection to these clones and then assayed individual gancyclovir resistant clones for one of the recombinant products, attR, by PCR. The six integrases that had shown clearly detectable activity in the transient transfection experiment (R4, φC31, φBT1, Bxb1, SPBc and Wβ) showed activity after stable expression of the integrase (Figure 4A). The remaining integrases showed no evidence for site-specific recombinase activity following gancyclovir selection. We wanted to determine how accurately the six active integrases were mediating site-specific recombination. We therefore sequenced at least 7 PCR products containing recombinant attR sites derived from each of the six active integrases and showed that, with the notable exception of the R4 integrase, all exclusively yielded products that were consistent with conservative site-specific recombination (Table 2). In the case of the R4 integrase only 2/9 PCR products contained intact attR sites, demonstrating that this enzyme seems particularly damage prone, at least in human cells.
We wanted to know whether the complete failure to detect deletion activity after two weeks of growth in the presence TP901-1, FC1, φ370.1, K38, φRV, A118, BL3 and MR11 integrases was because these recombinases were slow or because they were damaging the target sites. We therefore applied hygromycin selection to the second group of clones that had been stably transfected with the integrase expression construct but not exposed to gancyclovir, then relaxed hygromycin selection and analysed the clones for any detectable recombination after a further two weeks by PCR. The results were clear; TP901-1 integrase showed detectable recombination after further culture indicating that it was indeed slow but the remaining integrases showed no evidence of recombination (Additional file 1: Table S4). As before we determined the sequence of the PCR products containing the predicted attR site generated by the TP901-1 integrase; 4 were intact attR sites and 1 was damaged thus showing that TP901-1 integrase is like the R4 integrase and prone to site damage. We wanted to know whether the remaining 8 integrases that had failed to show productive recombination were attempting recombination but were in fact damaging the attachment sites. We therefore sequenced their substrate attachment sites (attP and attB) in the integrated reporter plasmids in two of the hygromycin resistant clones that had been transfected with the respective integrase expression constructs. None showed evidence of site damage.
Thus we concluded that the R4, φC31, φBT1, Bxb1, SPBc, TP901-1 and Wβ integrases are active on substrates integrated in to the genome of HT1080 cells although the TP901-1 integrase promotes recombination slowly and that the FC1, φK38, RV, A118, BL3 and MR11 integrases are not detectably active on integrated substrates. We cannot make any statement about the TG1 and φ370.1 integrases because we were unable to recover clones expressing these integrases for experimental analysis. We attempted to use western blotting to assay for expression of the integrases using with an antibody to the N-terminal StrepII tag but we were unable to detect any signal with any of the integrases suggesting that they are all expressed at low levels. Rank ordering of the deletion activities of the integrases in this experiment indicated the following Bxb1 = φC31 = φBT1 > R4 = Wβ > SPBc > TP901-1. The utility of the R4 integrase would seem to be limited by its liability to site damage. The purpose of this part of our project was to identify those enzymes that were active in vertebrate cells and we did not investigate the background of GANCrattR- clones. Although such clones were seen in the cells transfected with the empty vector and may arise from background silencing of the attP CCAG HyTK attB indicator gene or from loss of the chromosome carrying this gene, they occur at a higher level in the clones that had been transfected with integrases (Additional file 1: Table S4). We cannot exclude the possibility that they arise as a result of recombinase-mediated target site damage, although the accurate recombination activities seen with five of the seven active integrases would suggest that this is unlikely. The source of these background clones is therefore unclear.
It is also clear that not all of the clones that were successfully transfected with a construct expressing an active integrase yielded recombinant products. Thus even with the Bxb1 and φC31 integrases about 30% of the clones that were resistant to the antibiotic used to select for the presence of the expression construct failed to yield clones that were resistant to gancyclovir and contained an attR site. One hypothesis was that these clones failed to express sufficient integrase to bind and synapse the substrates, processes that are dependent on the affinity of integrase for its attP and attB sites and the expression level of integrase. We tried to test this idea by using the StrepII epitope with which we had tagged all of the integrases but, as before, were unable to do so for all of the integrases because the StrepII epitope tag was insufficiently sensitive and no signal was obtained in the western blots. However we had specific polyclonal antibodies for the φC31 and φBT1 integrases that we expected would be more sensitive and indeed they allowed us to measure the presence of the respective integrases by western blotting,. The results of this analysis was consistent with the notion that at least for some integrases the failure of site-specific recombination was associated with inadequate or low levels of expression (Additional file 1: Figure S2). The success of the western blotting using the polyclonal antibodies also demonstrates that the previous failure to detect integrase expression in the human cells using the StrepII tag and antibody was due to the relatively low sensitivity of this system.
The results obtained with the human HT1080 cells posed the question of whether they were generally true for vertebrate cells. Genome engineering of mouse embryonic stem cells (ES cells) is widely practiced and so we used a deletion strategy to assay the activities of the integrases in mouse ES cells. We used sequence targeting to introduce the attP array CCAG HyTK attB array deletion reporter cassette into the ROSA26 locus (Additional file 1: Figure S1) and then assayed for deletion by gancyclovir resistance following transient transfection with the set of integrase expression constructs described above. In order to avoid problems with toxicity that would compromise the practical significance of any results we chose to use transient assays and an internal control to carry out the experiment. In this ES cell system there appeared to be a clearer difference between the numbers of gancyclovir-resistant clones seen with the empty vector and those with expressing integrase than was observed in the HT1080 cells. The difference was not absolute however and identification of active integrases also required PCR analysis for the presence of a recombinant attR site. The results (Additional file 1: Table S5 and Figure 4B) were similar but not identical to those seen in the HT1080 cells; R4, φC31, φBT1, Bxb1, SPBc, Wβ and TG1 integrases showed detectable activity but the TP901-1 integrase did not. The activity seen with the TG1 integrase was, however, weaker than seen with the others with only one out of eight clones containing a detectable attR site. Rank ordering of the deletion activities of the integrases in this experiment indicated the following Wβ > Bxb1 > φC31 > SPBc > R4 > φBT1. We analyzed the accuracy of the site-specific recombination mediating the deletion reaction in two gancyclovir-resistant clones generated by the Bxb1, R4, Wβ and SPBc integrases. These results demonstrated that the Bxb 1, φBT1 and Wβ integrases all mediated site-specific recombination accurately but that the R4 integrases was associated with a deletion in one of the two recombination products analyzed and that both of the SPBc products were deleted. In the case of the SPBc integrase the region deleted 171 bp in the attP array extending as far as the φ370.1 attP site raising the possibility of a lack of specificity in attP site recognition by the integrase. This however seems unlikely because the breakpoint in the φ370.1 attP site is not at the proposed recombination junction but 6 bp 3′ of the point of symmetry defining the pseudo-palindrome of this attachment site.
The failure to detect recombinase activity mediated by the φ370, FC1, TG1, RV, FC1, φK38, MR11, A118 and BL3 integrases in HT1080 cells using deletion substrates integrated into the vertebrate genome posed the question as to whether these integrases were active in HT1080 cells or whether they were simply prevented from acting by the fact that the target sites were integrated into the genome. We therefore carried out a series of transient tranfection experiments in which the deletion substrate plasmid was transiently transfected into HT1080 cells that had been stably transfected with an expression plasmid for one of these integrases or, in the case of the φ370 and TG1 integrases,(where such stably transfected cell lines did not exist) co-transfected the respective expression plasmid and deletion substrate plasmid and then analyzed the extracted DNA for deleted plasmid after 72 hours by PCR. The recombinants were assayed using one of two PCR reactions for which the Bxb 1 or Wβ integrases acted as positive controls. The results (Figure 4C) demonstrate that the RV, φK38, MR11, A118 and BL3 integrases were in fact active in the HT1080 cells and thus we conclude that these integrases are unable to promote site-specific recombination when their substrates are integrated into the genome of the HT1080 cells but can do so when they are present extra-chromosomally. We can make no statement about the φ370, FC1, TG1 integrases as we have no evidence to determine whether they are expressed.
Comparative integration activities of seven unidirectional phage integrases in mammalian cells assayed by recombinase mediated cassette exchange
Site-specific integration, and in particular the exchange of marker cassettes, collectively termed recombinase mediated cassette exchange, is an important technique for the precise introduction of DNA into cells, in particular for the comparative analysis of different genes integrated at the same docking site. The uni-directional serine integrases are ideally suited to this application as they require only simple attachment sites and no host accessory proteins. We wanted to determine which of the seven integrases that we had identified above as being active in promoting site-specific deletion in human cells, also functioned in promoting site-specific cassette exchange. Our previous experiments had shown the merits of using cell lines that contained arrays of attachment sites that were then stably transfected with different integrase-expressing plasmids as reagents for accurate comparisons of integrase activity. We first introduced an integration target; attP array CCAG HyTK attP array expressing the hygromycin-thymidine kinase fusion flanked by arrays of attP sites into human HT1080 cells by electroporation and, as before, selected structurally intact, single copy integrants. We then transfected these cells with individual integrase expression plasmids for each of the seven integrases that had been shown to be active in the deletion assay and again selected for stable integrants. In order to compare the cassette exchange activities of the different integrases we then transiently transfected two completely independent clones with the integration substrate, attB array CCAG Neo attB array (Figure 2). The work described above indicated that the integrases were toxic to varying degrees (Additional file 1: Table S4) and so we expected that there would be different numbers of resistant clones derived from the transfection experiments of clones expressing different integrases, despite similar amounts of plasmid being used in the transfection. We controlled for such differences by transfecting the integrase-expressing clones with a linearized CCAG Neo plasmid in a parallel experiment carried out at the same time as they were transfected with the circular attB array CCAG Neo attB array plasmid. We selected for G418 resistance in both cases and normalized the experimental transfections using the yield of clones generated following transfection with the linearized CCAG Neo. We then assayed for cassette exchange in the experimental clones by selecting the G418 resistant clones for gancyclovir resistance to identify those clones that had lost the CCAG HyTK marker and by PCR in order to identify the attL and attR products of a site-specific recombination reaction. We carried out three such assays on two independent attP CCAG HyTK attP, integrase-expressing clones. The results (Additional file 1: Table S6, Figure 5A) of these experiments revealed consistent and significant differences between the seven integrases in terms of their abilities to mediate site-specific integration. At one extreme were the Bxb1 and φC31 integrases which promoted efficient and accurate site specific integration and at the other were the three integrases Wβ, SPBc and TP901-1 which generated clones that had the phenotypes expected of cassette exchange through site-specific recombination i.e. they were gancyclocvir -resistant and G418-resistant, but for which we could not obtain PCR products for attL or attR. We sequenced the attL and attR sites generated by site-specific integration in the Bxb1, φC31, R4 and φBT1 integrase-expressing clones. The Bxb1 and φC31 integrases products were as predicted but in three cases the attR product generated by the R4 integrase was damaged and similarly one of the three attR sites generated by the φBT1 integrase was also damaged. The experimental results shown in Additional file 1: Table S6 could be interpreted to suggest that there is a high background of non-specific integration of the circular plasmids into the genome of the HT1080 cells in the absence of any integrase. Such an interpretation would only be valid however if it the cells containing the empty expression vector were transfected with equal efficiency to those expressing any of the integrases. Given the toxicity of the integrases seen in the results shown in Additional file 1: Table S4 this is almost certainly not the case and thus the relatively apparently high background of non-specific integration simply reflects the fact that the cells that do not express integrase are just more easily transfected than those that do.
We wanted to understand how the gancyclocvir-resistant, G418-resistant, attL-, attR- clones had been generated by the Wβ, SPBC and TP901-1 integrases. First of all we wanted to confirm that indeed these integrases were active in the human cells and in order to investigate this we assayed extra-chromosomal site-specific recombination following transient transfection. We therefore took one of the clones expressing each of these integrases and Bxb1 integrase as a control and then transiently transfected the cells with the integration substrate plasmids either alone or together and then confirmed site-specific recombination by PCR for each of the respective attR and attL sites (Figure 5B). We supposed that the gancyclocvir-resistant, G418-resistant, attL-, attR- clones generated by these recombinases arose as a result of DNA damage arising as a result of abortive recombination. We therefore characterized the structure of the remains of the docking site (the attP array CCAG HyTK attP array plasmid) and the integrated attB array CCAGNeo attB array plasmid in 10 clones derived by transfection of either the Wβ or TP901-1 integrase expressing clones (Figure 6A). This analysis showed evidence of target site damage with extensive deletion of the HyTK coding region and flanking sequences. In the case of the TP901-1 integrase six of the clones (numbers 3, 5, 7, 8, 9 and 10) the internal sequences (2, 3 and 4 in Figure 6A) were deleted but flanking sequences (1 and 5 in Figure 6A) were intact suggesting the possibility that the two attP sites had simply ligated together after deletion of the intervening DNA. We therefore analysed the residual attP sequences in three clones: two, numbers 4 and 9, showed evidence of deletion of the residual attP sequences (Figure 6B) while in a third, number 8, the residual attP sequence was intact. For both integrases the incoming attB array CCAG Neo attB array plasmid also showed evidence of DNA damage, but in this case the damage was associated with the DNA flanking the cognate attachment sites. Thus in eight out of ten of the Wβ derived clones one or other of the attachment sites showed evidence of damage and three out of the ten TP901-1 derived clones showed evidence of damage to one or other of the attachment sites. The conclusion that we draw from these studies is that DNA damage is limiting the ability of the Wβ, SPBc and TP901-1 integrases to mediate site-specific recombination and cassette exchange in vertebrate cells and compromises the potential utility of the R4 and φBT1 integrases. However we are able to rank the utility of the other four enzymes: Bxb1 > φC31 > R4 > φBT1.
As before we also tried to assay the ability of these seven enzymes to mediate site-specific integration in mouse cells using transient expression of the integrase. None were detectably active suggesting that as in human cells detectable integration with this configuration of attachment sites requires stable expression of the integrase.
The major conclusion following from this work is that although all of the fifteen unidirectional serine integrases for which both attachment sites have been identified are active in E.coli, only four of these; Bxb1, φC31, R4 and φBT1 are able to mediate accurate site-specific integration into genomic DNA in human cells and rank such that Bxb1 is marginally better than φC31 and both are better than R4 and φBT1 integrases. The three integrases from the phages Wβ, SPBc, TP901-1 are active in vertebrate cells as judged by their ability to mediate site-specific deletion and by their ability to mediate integration reactions extra-chromosomally but fail to complete successful site-specific integration when attempting an integration by cassette exchange because they damage one or other of the participating DNA molecules. Although there are differences (Figure 4) between the activities seen with the different integrases in human and mouse cells the data the overall pattern of activites in the two cell types is such that it would seem prudent to adopt the B×b 1 integrase as the first choice in both. We have not investigated the causes of the different activities but they must reflect interactions between the respective integrases and host encoded proteins.
Our observations have three practical implications and pose one question. The practical implications are first that the B×b 1 integrase should be the first choice for any genome engineering in vertebrate cells that requires the use of a serine integrase. Second, that screening for more serine integrases that can be used in vertebrate cells is likely to have a low success rate and, third, that it is necessary that all site-specific integrants, particularly those generated by the R4 and φBT1 integrases should be checked for the fidelity of the recombination reaction.
The results obtained in the integration experiments with the Wβ, SPBc, TP901-1 integrases pose the question of how such damage arises. One possible mechanism is set out in Figure 7. In this schema one or other of the attachment sites on the incoming donor plasmid, attB array CCAG neo attB array forms a synaptic complex with an attP site in the integrated docking cassette located on attP CCAG HyTK attP. The attP and attB sites are then cleaved but because the two participating sites are embedded in chromatin, strand exchange and/or re-joining of the DNA backbone are inhibited. Possibly the intermediate complex, containing the covalent attached integrase subunits to the cleaved DNA, is unstable and dissociates, or the process of strand exchange by subunit rotation is interrupted. The cleaved DNA covalently linked to integrase subunits leads to resection of the target attP site by DNA repair pathways which in turn leads to loss of the counter-selectable HyTK gene (Figure 7A). The concomitant double strand break in the attB array CCAG neo attB array plasmid enables this plasmid to integrate efficiently elsewhere in the genome (Figure 7B). However not all of the gancyclovir-resistant, G418-resistant, attL-, attR- clones recovered following transfection of the Wβ or TP901-1 integrase expressing lines showed evidence of damage at one or other of the donor attB sites and one assumes that these clones arise by a similar but more complicated mechanism in which the transfected cell takes up more than one of the these plasmids and that it is one of the plasmids that have not participated in the abortive attempt at site specific integration that integrates into the host cell genome.
If chromatin is inhibiting strand exchange by the serine integrases, one might also have reasonably expected chromatin to alter other activities of integrase such as site-selection. In vitro φC31 integrase only recombines attP × attB and is never active on other pairs of attachment sites including attP with attP or attB with attB. This site-selectivity is explained as only integrase dimers bound to attP and to attB can tetramerise to form the synaptic complex. Within this complex activation of DNA cleavage occurs. In all of our experiments we did not observed altered site-selectivity or DNA damage arising from some attempt at recombination of two attP sites or two attB sites. The absence of any change in site-selectivity in eukaryotic chromatin implies that the proposed conformational differences between integrase bound to an attP site and to an attB site are robust to withstand any fortuitous protein-protein interactions arising with chromatin.
The differences seen between the activities of the integrases in E. coli and in vertebrate cells on extra-chromosomal substrates on one hand and on substrates integrated into the genome on the other and the explanation for the site damage seen in the integration reactions both suggest that chromatin and other DNA binding proteins are important factors in limiting the activity of site-specific recombinases in vertebrate cells. It may therefore be of value in future experiments to determine how the activity of the integrases vary according to the position of the target sites in the genome.
Bacterial strains, plasmids and molecular biology
E. coli K12 DH5α was used as a general cloning host and propagated on LB medium containing appropriate supplements or antibiotics (ampicillin (100 μg/ml), chloramphenicol (50 μg/ml), X-gal (120 μg/ml), IPTG (40 μg/ml). E. coli BL21 (DE3) was used as a protein over-expression host. To construct the integrase expression plasmids, the integrase genes were amplified by PCR from either phage templates or from plasmids and inserted into pET21a vector (Novagen) using either the In-Fusion cloning system (Clontech) or T4 ligase and compatible restriction sites. The native sequences were used as the templates for the amplification of all integrase genes except for φC31, A118, FC1 and φK38 for which templates were derived from synthetic, codon optimised forms (Genescript). Each integrase gene was modified to include a StrepII tag at the 5′ end and a nuclear localisation sequence (NLS) at the 3′ end. Reporter plasmids containing cognate attP and attB sites for all the integrases were cloned into pACYC184. PCR was used to amplify the lacZα gene using forward and reverse primers that contained the attB and attP sites (both approximately 50 bp in length) in head-to-tail orientation (Additional file 1: Table S1). All of the constructed plasmids were verified by sequencing (Dundee Sequencing Service). The sequences of all PCR plasmids and primers used in the bacterial work are listed in Additional file 1: Table S1 and Additional file 1: Table S2.
Recombination assays in E. coli
The activities of the cloned integrases in E. coli were assessed by two assays, which relied on different expression regimes for the integrases. The expression vector pET21a has a T7 RNA polymerase promoter to drive the transcription of the integrase genes and this was used to ensure expression of the integrase genes in the E. coli host BL21(DE3). In the absence of T7 RNA polymerase, as is the case in E. coli DH5a, expression of integrase is dependent on the recognition of the T7 promoter by host RNA pol ymerase, which will result in lower expression.
DH5α cells containing the attB/attP reporter plasmids were transformed with the appropriate integrase expression plasmid and plated out on LB agar plates containing ampicillin (100 μg/ml), chloramphenicol (50 μg/ml), X-gal (120 μg/ml), IPTG (40 μg/ml) and incubated overnight at 37°C. Recombination between the att sites deletes the lacZα gene from the reporter plasmid leading to white colonies and therefore recombinants (white colonies) were scored amongst a background of non-recombinants (blue colonies). The transformation plates derived from several integrases gave rise to only blue or light blue colonies. Restreaking of these colonies was performed to determine if white colonies (containing recombinant reporter plasmids) could segregate.
BL21(DE3) cells containing the attB/attP reporter plasmids were transformed with the appropriate integrase expression plasmid and plated out on LB agar plates containing ampicillin and chloramphenicol. After an overnight incubation a single colony was picked and grown in 5 ml 2YT containing ampicillin and chloramphenicol for 5 h at 37°C. The cells were induced with IPTG and grown overnight at 20°C after which 1 ml of this culture was used to prepare plasmid and the pellet from 4 ml was used in Western blotting to estimate the expression of integrase. Plasmids extracted from the overnight culture were used to transform DH5α cells and colonies growing on plates containing chloramphenicol, X-gal and IPTG after overnight at 37°C were examined. The proportion of recombinant versus non-recombinant plasmids was scored from the proportion of white versus blue transformants. PCR was carried out on 5 individual colonies for each integrase used in the assay to amplify and sequence the attL sites, remaining in the recombinant plasmids. Cell pellets from the overnight cultures were resuspended in LB, incubated in SDS sample buffer and the proteins separated on a 4-12% SDS gel (Expedeon, UK). The integrase protein was detected by Western blotting using a monoclonal antibody against the StrepII tag conjugated to horseradish peroxidise (IBA, Germany). The amount of protein present was determined by comparing the intensities of the bands from the Western blotting to those from a dilution series of purified StrepII-tagged φC31 integrase. The intensity of the bands was determined using ImageJ (NIH) and the results were expressed as μg of total protein per ml culture.
In vitrorecombination assay
Integrase recombination activity was assayed in vitro using substrates in which the attachment sites were present either isolated from other attachment sites or within the arrays containing the attachment sites for all 15 integrases of interest. The combination of substrates was as follows: pRT702 (φC31 attP site) and pRT600 (φC31 attB site), pRT702 and pUC57_attB array, pUC57_attP array and pRT600, pUC57_attP array and pCCAG_attB array, pCCAG_attP array and pUC57_attB array. The substrates were incubated in recombination buffer (10 mM Tris pH 7.5, 100 mM NaCl, 5 mM DTT, 5 mM spermidine, 4.5% glycerol, 0.5 mg/ml BSA) and φC31 integrase (0 – 700 nM) for 1 h at 30°C  After heat inactivation at 80°C for 10 min the reaction was digested with HindIII or BamHI and the recombination molecules detected by gel electrophoresis. Gel images were analysed using ImageJ (NIH); the intensity of the bands was determined (after subtraction of base line intensities) and used to quantify the depletion of substrates and appearance of products.
Human cell culture
Human HT1080 fibrosarcoma cells were grown as described previously except that RPMI 1640 rather than Dulbecco’s modified Eagles Medium was used as the un-supplemented medium. G418, Hygromycin and gancyclovir (Invitrogen) were used at 400 mg/ml, 100 mg/ml and 20 μM respectively for selection. Cells were transfected with DNA either by electroporation using a BTX ECM 630 at 400 V, 50 Ω and 250 μF or using Lipofectamine (Invitrogen) as recommended by the manufacturers. We used electroporation with 500 μg of linearized DNA and zeocin selection for the stable introduction of the integrase expression constructs and lipofection of 1.6 μg of closed circular DNA for the transient introduction of either substrate or integrase expression construct.
ES cell manipulation and analysis
Targeting vector construction and gene targeting
The insertion of the attP-Hygro-TK-attP array at the ROSA26 locus was performed by gene targeting in E14tg2a ES cells (Additional file 1: Figure S1). A targeting vector for the ROSA26 locus, pRosa26.10  was adapted by the insertion of an AscI-NsiI-SacII polylinker, made by oligonucleotide annealing, into the AscI and SacII sites 3′ and 5′ of the homology arms, creating plasmid pRosa26-PL. The final targeting vector, pRosa26-PHB containing the attP-Hygro-TK-attB arrays, was constructed by inserting the arrays from pBSattPCCAGHyTKattB into pROSA26-PL via the 5′ AscI and the 3′ NsiI sites.
The targeting vector was linearized by XhoI digestion and electroporated into 1×107 E14tg2a cells at 500 V, 3 uF. Cells were plated on gelatin and recombinant clones were recovered by selection in Hygromycin 75 ug/ml. Targeted clones were identified by long range PCR screening using primers 5′-GGCACTACTGTGTTGGCGGA-3′ and 5′-GGCCAGCTTATCGATACCGT-3′ for the 5′ end; 5′-AGCGAGGGCTCAGTTGGGCTGTTT-3′ and 5′-CTCAGTGGCTCAACAACACTTGGTCA-3′ for the 3′ end. Single copy integration events were confirmed by Southern blotting using an EcoRV digest and an internal Hygromycin probe.
Transient assays of integrase-mediated deletion in ES cells
1 × 106attP-Hygro-TK-attB ES cells were electroporated with 5 μg of the integrase vectors and 200 ng of a control plasmid containing a functional neomycin cassette to control for transfection efficiency. Electroporation was performed using the Neon transfection system (Invitrogen) (3 × 1400 V, 10 ms). Cells were plated on 2 wells of a 6 well plate and selected in either 3 μM Gancyclovir or 350 μg/ul G418. On the 8th day of selection resistant colonies were stained in methylene blue and counted. Deletion efficiencies were calculated from the number of gancycolvir resistant colonies normalised against transfection efficiency by assessing the number of G418 resistant clones in the replica plating. All comparison transfection experiments were repeated twice using 2 independently targeted ES cell clones.
Individual gancyclovir resistant colonies were picked and expanded for the preparation of genomic DNA. PCR analysis using primers del-Rosa-F1 (5′ GATCGAGGTGCCCCAACTGGGGTAACCT TT-3′) and del-Rosa-R1 (5′-CCGCGGATGCATAGCGGATAACAATTTCAC-3′) which bind at the very 5′ and 3′ of the integrated attP-Hygro-TK-attB array and amplify across the expected deletion events (Additional file 1: Figure S1), was performed to confirm the deletion event had occurred. PCR products were sequences to assess the nature and position of the attP x attB recombination and the sequences of the resulting attR sites. Gancyclovir resistant clones that failed to yield an amplicon using this PCR strategy were further investigated for aberrant recombination events using primers which amplify the hygromycin sequence (5′- GAAGAATCTCGTGCTTTCAGCTTCGATG-3′; 5′- AATGACCGCTGTTATGCGGCCATTG-3′) and the thymidine kinase sequence (5′-TCTGGACCGATGGCTG TGTA-3′; 5′-AGACGTGCATGGAACGGAGG-3′).
Brown WR, Lee NC, Xu Z, Smith MC: Serine recombinases as tools for genome engineering. Methods. 2011, 53 (4): 372-379. 10.1016/j.ymeth.2010.12.031.
Ghosh P, Wasil LR, Hatfull GF: Control of phage Bxb1 excision by a novel recombination directionality factor. PLoS Biol. 2006, 4 (6): e186-10.1371/journal.pbio.0040186.
Khaleel T, Younger E, McEwan AR, Varghese AS, Smith MC: A phage protein that binds phiC31 integrase to switch its directionality. Mol Microbiol. 2011, 80 (6): 1450-1463. 10.1111/j.1365-2958.2011.07696.x.
Seibler J, Bode J: Double-reciprocal crossover mediated by FLP-recombinase: a concept and an assay. Biochemistry. 1997, 36 (7): 1740-1747. 10.1021/bi962443e.
Belteki G, Gertsenstein M, Ow DW, Nagy A: Site-specific cassette exchange and germline transmission with mouse ES cells expressing phiC31 integrase. Nat Biotechnol. 2003, 21 (3): 321-324. 10.1038/nbt787.
Turan S, Zehe C, Kuehle J, Qiao J, Bode J: Recombinase-mediated cassette exchange (RMCE) - a rapidly-expanding toolbox for targeted genomic modifications. Gene. 2013, 515 (1): 1-27. 10.1016/j.gene.2012.11.016.
Dafhnis-Calas F, Xu Z, Haines S, Malla SK, Smith MC, Brown WR: Iterative in vivo assembly of large and complex transgenes by combining the activities of phiC31 integrase and Cre recombinase. Nucleic Acids Res. 2005, 33 (22): e189-10.1093/nar/gni192.
Andreas S, Schwenk F, Kuter-Luks B, Faust N, Kuhn R: Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. Nucleic Acids Res. 2002, 30 (11): 2299-2306. 10.1093/nar/30.11.2299.
Xu Z, Lee NC, Dafhnis-Calas F, Malla S, Smith MC, Brown WR: Site-specific recombination in Schizosaccharomyces pombe and systematic assembly of a 400kb transgene array in mammalian cells using the integrase of Streptomyces phage phiBT1. Nucleic Acids Res. 2008, 36 (1): e9-
Russell JP, Chang DW, Tretiakova A, Padidam M: Phage Bxb1 integrase mediates highly efficient site-specific recombination in mammalian cells. Biotechniques. 2006, 40 (4): 460-462. 10.2144/000112150. 464,
Yamaguchi S, Kazuki Y, Nakayama Y, Nanba E, Oshimura M, Ohbayashi T: A method for producing transgenic cells using a multi-integrase system on a human artificial chromosome vector. PLoS ONE. 2011, 6 (2): e17267-10.1371/journal.pone.0017267.
Olivares EC, Hollis RP, Calos MP: Phage R4 integrase mediates site-specific integration in human cells. Gene. 2001, 278 (1–2): 167-176.
Stoll SM, Ginsburg DS, Calos MP: Phage TP901-1 site-specific integrase functions in human cells. J Bacteriol. 2002, 184 (13): 3657-3663. 10.1128/JB.184.13.3657-3663.2002.
Keravala A, Groth AC, Jarrahian S, Thyagarajan B, Hoyt JJ, Kirby PJ, Calos MP: A diversity of serine phage integrases mediate site-specific recombination in mammalian cells. Mol Genet Genomics. 2006, 276 (2): 135-146. 10.1007/s00438-006-0129-5.
Malla S, Dafhnis-Calas F, Brookfield JF, Smith MC, Brown WR: Rearranging the centromere of the human Y chromosome with phiC31 integrase. Nucleic Acids Res. 2005, 33 (19): 6101-6113. 10.1093/nar/gki922.
Grindley ND, Whiteson KL, Rice PA: Mechanisms of site-specific recombination. Annu Rev Biochem. 2006, 17: 567-605.
Thorpe HM, Smith MC: In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci USA. 1998, 95 (10): 5505-5510. 10.1073/pnas.95.10.5505.
Ghosh P, Kim AI, Hatfull GF: The orientation of mycobacteriophage Bxb1 integration is solely dependent on the central dinucleotide of attP and attB. Mol Cell. 2003, 12 (5): 1101-1111. 10.1016/S1097-2765(03)00444-1.
Gregory MA, Till R, Smith MC: Integration site for Streptomyces phage phiBT1 and development of site-specific integrating vectors. J Bacteriol. 2003, 185 (17): 5320-5323. 10.1128/JB.185.17.5320-5323.2003.
Park MO, Lim KH, Kim TH, Chang HI: Characterization of site-specific recombination by the integrase MJ1 from enterococcal bacteriophage phiFC1. J Microbiol Biotechnol. 2007, 17 (2): 342-347.
Rashel M, Uchiyama J, Ujihara T, Takemura I, Hoshiba H, Matsuzaki S: A novel site-specific recombination system derived from bacteriophage phiMR11. Biochem Biophys Res Commun. 2008, 368 (2): 192-198. 10.1016/j.bbrc.2008.01.045.
Breuner A, Brondsted L, Hammer K: Novel organisation of genes involved in prophage excision identified in the temperate lactococcal bacteriophage TP901-1. J Bacteriol. 1999, 181 (23): 7291-7297.
Bibb LA, Hancox MI, Hatfull GF: Integration and excision by the large serine recombinase phiRv1 integrase. Mol Microbiol. 2005, 55 (6): 1896-1910. 10.1111/j.1365-2958.2005.04517.x.
Canchaya C, Desiere F, McShan WM, Ferretti JJ, Parkhill J, Brussow H: Genome analysis of an inducible prophage and prophage remnants integrated in the Streptococcus pyogenes strain SF370. Virology. 2002, 302 (2): 245-258. 10.1006/viro.2002.1570.
Fouts DE, Rasko DA, Cer RZ, Jiang L, Fedorova NB, Shvartsbeyn A, Vamathevan JJ, Tallon L, Althoff R, Arbogast TS, et al: Sequencing Bacillus anthracis typing phages gamma and cherry reveals a common ancestry. J Bacteriol. 2006, 188 (9): 3402-3408. 10.1128/JB.188.9.3402-3408.2006.
Smith MC, Till R: Switching the polarity of a bacteriophage integration system. Mol Microbiol. 2004, 51 (6): 1719-1728. 10.1111/j.1365-2958.2003.03942.x.
Hitz C, Wurst W, Kuhn R: Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference. Nucleic Acids Res. 2007, 35 (12): e90-10.1093/nar/gkm475.
This work was supported by BBSRC grant: BB/H005277/1; New recombinases for genome engineering.
The authors declare that they have no competing interests.
Zy X, LT and BD carried out experimental work, WB, MS and BD designed the experiments, RC conceived the project. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Table S1: Plasmids used to assay integrase activity in E.coli, Table S2. Primers used to construct expression plasmids and assay integrase activity in E.coli, Table S3. The results of two transient transfection experiments in which the integrase shown in the first column was introduced into each of two cell lines containing a single copy of the deletion assay reporter plasmid located intact at a single site in the genome of HT1080 cells. Table S3. Assaying integrase activity in human HT1080 cells by deletion activity following transient transfection of integrase expression plasmid, Table S4. Assaying integrase activity in human HT1080 cells by deletion activity following genomic integration of integrase expression plasmid, Table S5. Assaying integrase activity in mouse ES cells by deletion activity following transient transfection of integrase expression plasmid, Table S6. Assaying site-specific integration activity of seven integrases able in human HT1080 cells, Table S7. Primers used to analyse re-arrangements associated with cassette exchange integrations: illustrated in Figure 6 of main text, Figure S1. (A) Targeting the ROSA26 locus in mouse ES cells with a deletion reporter construct. (B) the targeted locus before deletion (C) the targeted locus after deletion. Sequences of the Del-Rosa primers are in the main text, Figure S2. western blot analysis of φC31 and φBT1 integrase expression in HT1080 clones that contain a single integrated copy of the attP array CCAG HyTk attB array reporter and have been stably transfected with an integrase expression plasmid but fail to delete the HyTk gene. (DOCX 2 MB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Xu, Z., Thomas, L., Davies, B. et al. Accuracy and efficiency define Bxb1 integrase as the best of fifteen candidate serine recombinases for the integration of DNA into the human genome. BMC Biotechnol 13, 87 (2013) doi:10.1186/1472-6750-13-87
- Serine recombinases
- Genome manipulation
- DNA damage